Effect of low-level BCR-ABL1 kinase domain mutations identified by next-generation sequencing in patients with chronic myeloid leukaemia: a population-based studyAytug Kizilors, Hugues de Lavallade, Clare Wykes et al.|The Lancet Haematology|2019Cited by 56